“The Applicant evaluated the toxicity profile of mobocertinib in Sprague-Dawley rats and Beagle dogs in GLP-compliant studies with treatment durations up to 3 months.”
✓ VerifiedFDA multi-discipline review, p. 42Source ↗
Pivotal GLP studies
3-month (13-week) oral studies in rats and dogs
“The Applicant evaluated the toxicity profile of mobocertinib in Sprague-Dawley rats and Beagle dogs in GLP-compliant studies with treatment durations up to 3 months.”
✓ VerifiedFDA multi-discipline review, p. 42Source ↗
Route in tox
Oral (gavage)
“A 3-Month Oral Study of TAK-788 by Oral Gavage in Sprague-Dawley Rats with a 1-Month Recovery Period/8002352 Amendment 1”
✓ VerifiedFDA multi-discipline review, p. 61Source ↗